Apolipoproteins J and E co-localise with amyloid in gelatinous drop-like and lattice type I corneal dystrophies

被引:30
作者
Nishida, I
Quantock, AJ
Dota, A
Choi-Miura, NH
Kinoshita, S [1 ]
机构
[1] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kamigyo Ku, Kyoto 602, Japan
[2] Showa Univ, Dept Physiol Chem, Tokyo, Japan
关键词
D O I
10.1136/bjo.83.10.1178
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aims-Apolipoprotein J (apoJ) and apolipoprotein E (apoE) are thought to contribute to amyloid formation in patients with Alzheimer's disease. The aim of this investigation was to discover whether or not these apolipoproteins associate with corneal amyloid in gelatinous drop-like corneal dystrophy (GDCD) and lattice corneal dystrophy type I (LCD-I). Methods-Corneas from three eyes of three patients with GDCD and one eye of one patient with LCD-I were examined immunohistochemically using antibodies against apoJ and apoE. Two normal corneas were similarly examined. Tissue sections of brain from a patient with Alzheimer's disease were used as positive controls for the antibodies. For all negative controls, mouse IgG was used instead of the primary antibody. Results-Intense apoJ and apoE immunoreactivities were found in congophilic amyloid deposits in GDCD and LCD-I. These deposits were located subepithelially in GDCD, and subepithelially and intrastromally in LCD-I. In GDCD, immunostaining of subepithelial amyloid with anti-apoJ was noticeably stronger than with anti-apoE. Conclusions-As in senile plaques in brain from a patient with Alzheimer's disease, apoJ and apoE co-localise with amyloid in corneas with GDCD and LCD-I.
引用
收藏
页码:1178 / 1182
页数:5
相关论文
共 38 条
[1]   Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition [J].
Bales, KR ;
Verina, T ;
Dodel, RC ;
Du, YS ;
Altstiel, L ;
Bender, M ;
Hyslop, P ;
Johnstone, EM ;
Little, SP ;
Cummins, DJ ;
Piccardo, P ;
Ghetti, B ;
Paul, SM .
NATURE GENETICS, 1997, 17 (03) :263-264
[2]   SANDWICH ELISA ASSAY FOR QUANTITATIVE MEASUREMENT OF SP-40,40 IN SEMINAL PLASMA AND SERUM [J].
CHOI, NH ;
TOBE, T ;
HARA, K ;
YOSHIDA, H ;
TOMITA, M .
JOURNAL OF IMMUNOLOGICAL METHODS, 1990, 131 (02) :159-163
[3]   SP-40,40 IS A CONSTITUENT OF ALZHEIMERS AMYLOID [J].
CHOIMIURA, NH ;
IHARA, Y ;
FUKUCHI, K ;
TAKEDA, M ;
NAKANO, Y ;
TOBE, T ;
TOMITA, M .
ACTA NEUROPATHOLOGICA, 1992, 83 (03) :260-264
[4]   Gelatinous drop-like corneal dystrophy is not one of the βig-h3-mutated corneal amyloidoses [J].
Dota, A ;
Nishida, K ;
Honma, Y ;
Adachi, W ;
Kawasaki, S ;
Quantock, AJ ;
Kinoshita, S .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1998, 126 (06) :832-833
[5]  
DOTA A, 1999, IN PRESS EXP EYE RES
[6]  
GHISO J, 1993, BIOCHEM J, V293, P27, DOI 10.1042/bj2930027
[7]   ALZHEIMERS-DISEASE - INITIAL REPORT OF THE PURIFICATION AND CHARACTERIZATION OF A NOVEL CEREBROVASCULAR AMYLOID PROTEIN [J].
GLENNER, GG ;
WONG, CW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (03) :885-890
[8]   GENETIC REFINEMENT OF THE CHROMOSOME-5Q LATTICE CORNEAL-DYSTROPHY TYPE-I LOCUS TO WITHIN A 2-CM INTERVAL [J].
GREGORY, CY ;
EVANS, K ;
BHATTACHARYA, SS .
JOURNAL OF MEDICAL GENETICS, 1995, 32 (03) :224-226
[9]   Lattice corneal dystrophy type 1 in a Canadian kindred is associated with the Arg124 → Cys mutation in the kerato-epithelin gene [J].
Gupta, SK ;
Hodge, WG ;
Damji, KF ;
Guernsey, DL ;
Neumann, PE .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1998, 125 (04) :547-549
[10]  
Harr SD, 1996, J NEUROCHEM, V66, P2429